SCHEMBL7381460

SCHEMBL7381460

CC1(C)C(=O)NN=C1c1ccc(-n2cncn2)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE3A Q14432 7/20 0.61
▸ PDE3B Q13370 5/20 0.61
▸ KDM4E B2RXH2 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP11B2 P19099 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ PDE4B Q07343 2/20 0.38
▸ ROCK1 Q13464 1/20 0.38
▸ FBP1 P09467 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ MMP13 P45452 1/20 0.35
▸ MMP14 P50281 1/20 0.35
▸ CYP2A6 P11509 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7377189 0.76 PDE3B (1.00) PDE3APDE3BCYP1A2CYP2D6CYP2C9
SCHEMBL16150009 0.71 PDE3A (0.55) PDE3APDE3BSMN1; SMN2ALDH1A1PDE4B
SCHEMBL2847376 0.71 PDE3A (0.55) PDE3APDE3BPDE4B
SCHEMBL16150403 0.71 PDE3A (0.55) PDE3APDE3BPDE4B
SCHEMBL16149750 0.71 PDE3A (0.55) PDE3APDE3BKDM4ESMN1; SMN2ALDH1A1
SCHEMBL7380645 0.71 PDE3A (0.54) PDE3APDE3BSMN1; SMN2ALDH1A1PDE4B
SCHEMBL7382252 0.69 PDE3B (0.58) PDE3APDE3BKDM4ESMN1; SMN2ALDH1A1
SCHEMBL2844753 0.69 PDE3A (0.52) PDE3APDE3BKDM4EPDE4B
SCHEMBL16150746 0.69 PDE3A (0.52) PDE3APDE3BKDM4EALDH1A1PDE4B
SCHEMBL7277988 0.69 PDE3B (0.60) PDE3APDE3BKDM4ESMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4661496-A Cardiotonic and antihypertensive 2,4-dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones WARNER-LAMBERT COMPANY (US) 1987-04-28 — — US disclosed
US-4550119-A 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones WARNER-LAMBERT COMPANY (US) 1985-10-29 — — US disclosed
US-4526982-A 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones WARNER-LAMBERT COMPANY, A CORP. OF DEL. 1985-07-02 — — US disclosed
EP-0126651-A2 2,4-Dihydro-5-((substituted)phenyl)-4,4-disubstituted-3H-pyrazol-3-ones, 2,4-dihydro-5-((substituted)phenyl)-4, 4-disubstituted-3H-pyrazol-3-thiones, and a process for producing the same WARNER-LAMBERT COMPANY (US) 1984-11-28 — — EP disclosed
Send feedback